JMP Securities Reiterates Market Outperform Rating for Foghorn Therapeutics (NASDAQ:FHTX)
Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a research report issued on Thursday,Benzinga reports. They currently have a $9.00 target price on the stock. JMP Securities’ price objective would suggest a potential upside of 103.16% from the company’s current price. Several […]
Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a research report issued on Thursday,Benzinga reports. They currently have a $9.00 target price on the stock. JMP Securities’ price objective would suggest a potential upside of 103.16% from the company’s current price. Several […]
